Epiphany has received the “Category Leader” recognition in ECG Management from KLAS for the fourth consecutive year.
An estimated 17 million people throughout the world die annually of cardiovascular diseases, specifically heart attacks or strokes. Time is a critical factor in diagnosing and treating people who may be having a potential heart attack. To aid physicians in detecting heart attacks sooner, Abbott announced CE marking for the Architect Stat High Sensitive Troponin-I Assay.
To help identify trends and find out what DAIC readers are interested in, the magazine takes note of what they click on when visiting the website. Below are the top 25 stories from 2012, and the top 10 stories read in 2012 that were written in previous years.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
In a study designed to see if doctors who are told the exact price of expensive medical tests like magnetic resonance imaging (MRI) in advance would order fewer of them, Johns Hopkins researchers got their answer: No.
According to Millennium Research Group (MRG), increasing awareness and diagnosis of peripheral vascular disease (PVD) along with the introduction of improved next-generation devices will lead the United States peripheral vascular (PV) device market to grow strongly to reach $3.3 billion by 2017.
AngioScore Inc. announced the launch of its new 100 mm length AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral artery disease (PAD) below the knee (BTK).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Fujifilm Medical Systems U.S.A. Inc. brought a broad portfolio of diagnostic and informatic solutions to the 2012 meeting of the Radiological Society of North America (RSNA). The company showcased its advanced Cardiovascular product, Synapse Cardiovascular 5.0.
January 25, 2013 — Mobile drug reference app provider Epocrates recently conducted its annual survey of cardiologists to uncover the biggest trends and challenges facing them today. The survey explores their perspectives on a range of issues related to patient care, healthcare technology usage/adoption and practice concerns. Following are some highlights from the survey findings.
The American College of Cardiology (ACC) has released the late-breaking clinical trials that will be highlighted as the cutting edge of cardiology at the ACC.13 annual meeting March 9-11 in San Francisco.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
BRIT Systems announced new capabilities for their digital imaging and communications in medicine (DICOM) routers that can pre-fetch studies from multiple servers and/or facilities based on select criteria that do not need to include the patient ID. The router morphs the patient ID in a pre-fetched study into the original or trigger ID, storing the pre-fetched IDs into alternate ID fields in both the database and the DICOM header. The new morphing router facilitates the creation of a single patient record and enables clinicians to view all studies on a single timeline. With this capability, clinicians will have access to a complete, cross-facility patient record that can be used to reduce unnecessary or duplicate imaging studies. The new capabilities were highlighted at the Radiological Society of North America (RSNA) annual meeting.
AirStrip Technologies Inc. announced that it has entered into a long-term strategic partnership with Vanguard Health Systems Inc.
The Spectranetics Corporation announced final results from the PATENT (Photo-Ablation using the TURBO-Booster(R) and Excimer Laser for In-Stent Restenosis Treatment) study evaluating the safety and efficacy of the Spectranetics peripheral laser atherectomy catheters for the treatment of in-stent restenosis (ISR) in the femoropopliteal artery in the leg. ISR occurs as a result of narrowing of the artery in patients who have undergone stenting for the treatment of peripheral arterial disease (PAD). There is currently no U.S. Food and Drug Administration (FDA)-cleared or approved device to treat peripheral in-stent restenosis, which remains a major unsolved medical problem.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
According to Millennium Research Group (MRG), the segment of the U.S. nonvascular interventional radiology device market with the fastest growth and greatest potential is ablation devices, comprising radiofrequency (RF) ablation, cryoablation and microwave ablation devices. The overall market will grow moderately to $295 million by 2017.
Bathing dangerous blood clots in special medication, breaking them up with jets of saline and vacuuming them out of the body is a fast, effective method of treating deep vein thrombosis (DVT), suggests data being presented at the 25th annual International Symposium on Endovascular Therapy (ISET).
St. Jude Medical Inc. announced European CE mark approval of its ViewFlex Xtra Intracardiac Echocardiography (ICE) Catheter. Designed for control and maneuverability during complex cardiac ablation procedures, the technology will be on display at the eighteenth annual Boston AF Symposium.